Consultado el 10 de octubre de 2025: Brito JP, Herrin J, Swarna KS, et al
Patent Information: 2026 Novo Nordisk For information about SAXENDA contact: Novo Nordisk Inc
& Mourrain, P
Tavernarakis, I.P
As long as you continue caring for your skin, the results stay
DL declares receipt of grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Pfizer and Sanofi, and past participation in advisory boards and/or receipt of honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Novartis, Pfizer, Sanofi and Shire, outside the submitted work